Nuvama Crossover Opportunities Fund - Series Iiia
Sudeep Pharma Limited · NSE
−5,62,360 sh · ₹47.80 Cr
SBI Mutual Fund
Fund
₹160.00 Cr
40,00,000 sh
SBI Healthcare Opportunities Fund
2.2% of their portfolio
₹119.82 Cr
13,60,000 sh
Goldman Sachs Funds - Goldman Sachs India Equity Portfolio
Investor
₹100.00 Cr
23,52,944 sh
HDFC Manufacturing Fund
69.0% of their portfolio
₹73.13 Cr
8,30,000 sh
SBI Comma Fund
5.1% of their portfolio
₹60.57 Cr
6,87,500 sh
SBI MNC Fund
93.0% of their portfolio
₹60.57 Cr
6,87,500 sh
SBI Retirement Benefit Fund - Aggressive Plan
1.2% of their portfolio
₹38.55 Cr
4,37,500 sh
Aditya Birla Sun Life Small Cap Fund
0.5% of their portfolio
₹25.97 Cr
3,06,092 sh
ICICI Prudential MNC Fund
1.1% of their portfolio
₹18.90 Cr
2,54,717 sh
SBI Retirement Benefit Fund - Aggressive Hybrid Plan
1.0% of their portfolio
₹16.52 Cr
1,87,500 sh
HDFC Innovation Fund
35.0% of their portfolio
₹10.40 Cr
1,18,050 sh
SBI Retirement Benefit Fund - Conservative Hybrid Plan
48.0% of their portfolio
₹1.23 Cr
14,000 sh
FII holding ~flat QoQ
Jun 2026 quarter
Ownership by quarter
Promoter
— 0.0pp
Nuvama Crossover Opportunities Fund - Series Iiia
Sudeep Pharma Limited · NSE
−5,62,360 sh · ₹47.80 Cr
Nuvama Crossover Opportunities Fund - Series III
Sudeep Pharma Limited · NSE
−6,14,112 sh · ₹52.20 Cr
Goldman Sachs Funds - Goldman Sachs India Equity Portfolio
Sudeep Pharma Limited · NSE
+11,76,472 sh · ₹100.00 Cr
Nuvama Crossover Opportunities Fund - Series III
Sudeep Pharma Limited · NSE
−6,14,112 sh · ₹52.20 Cr
Goldman Sachs Funds - Goldman Sachs India Equity Portfolio
Sudeep Pharma Limited · NSE
+11,76,472 sh · ₹100.00 Cr
HDFC Innovation Fund
Sudeep Pharma Limited · NSE
1,18,050 sh · ₹10.40 Cr
HDFC Manufacturing Fund
Sudeep Pharma Limited · NSE
8,30,000 sh · ₹73.13 Cr
SBI Comma Fund
Sudeep Pharma Limited · NSE
6,87,500 sh · ₹60.57 Cr
SBI Retirement Benefit Fund - Conservative Plan
Sudeep Pharma Limited · NSE
3,800 sh · ₹33.48 L
The announcements library is part of Pro.
Every exchange filing this company makes — results, board meetings, dividends, analyst meets, investor presentations — as filed with NSE / BSE, the day it lands.
24 announcements on record for this company.
Promoter holding by quarter: Dec 2025 76.2%, Mar 2026 76.2%.
FII
— −0.1pp
FII holding by quarter: Dec 2025 1.7%, Mar 2026 1.6%.
DII
— +0.5pp
DII holding by quarter: Dec 2025 17.6%, Mar 2026 18.1%.
MF
— +0.5pp
MF holding by quarter: Dec 2025 5.7%, Mar 2026 6.2%.
Per-series scale, bounds labeled. Gaps mark quarters without a filing.
Groww Mutual Fund (scheme NI)
Sudeep Pharma Limited · NSE
443 sh · ₹3.90 L
Ownership by quarter
Promoter
— 0.0pp
Promoter holding by quarter: Dec 2025 76.2%, Mar 2026 76.2%.
FII
— −0.1pp
FII holding by quarter: Dec 2025 1.7%, Mar 2026 1.6%.
DII
— +0.5pp
DII holding by quarter: Dec 2025 17.6%, Mar 2026 18.1%.
MF
— +0.5pp
MF holding by quarter: Dec 2025 5.7%, Mar 2026 6.2%.
Per-series scale, bounds labeled. Gaps mark quarters without a filing.
The announcements library is part of Pro.
Every exchange filing this company makes — results, board meetings, dividends, analyst meets, investor presentations — as filed with NSE / BSE, the day it lands.
24 announcements on record for this company.